SCHEMBL1742741

SCHEMBL1742741

CC(C)(C)OC(=O)N[C@H](C(=O)O)[C@@H](O[Si](C)(C)C(C)(C)C)c1ccc(C(F)(F)F)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 1/20 0.44
PPARA Q07869 1/20 0.44
AAK1 Q2M2I8 1/20 0.37
AKR1C3 P42330 2/20 0.35
AKR1C2 P52895 2/20 0.35
TRPA1 O75762 2/20 0.35
GABRB1 P18505 1/20 0.35
GABRB2 P47870 1/20 0.35
MMP1 P03956 1/20 0.34
MMP2 P08253 1/20 0.34
MMP3 P08254 1/20 0.34
MMP7 P09237 1/20 0.34
MMP9 P14780 1/20 0.34
MMP13 P45452 1/20 0.34
PDE2A O00408 3/20 0.34
EGFR P00533 1/20 0.34
CNR2 P34972 1/20 0.34
CTSS P25774 1/20 0.34
CTSK P43235 1/20 0.34
CYP26A1 O43174 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5019017 1.00 PPARG (0.44) PPARGPPARAAAK1AKR1C3AKR1C2
SCHEMBL1595742 1.00 PPARG (0.44) PPARGPPARAAAK1AKR1C3AKR1C2
SCHEMBL1742052 0.90 PPARG (0.39) PPARGPPARAAAK1AKR1C3AKR1C2
SCHEMBL1742055 0.90 PPARG (0.39) PPARGPPARAAAK1AKR1C3AKR1C2
SCHEMBL12241677 0.90 PPARG (0.39) PPARGPPARAAAK1AKR1C3AKR1C2
SCHEMBL12706285 0.86 PPARG (0.41) PPARGPPARAGABRB1GABRB2PDE2A
SCHEMBL5019025 0.86 TRPA1 (0.46) PPARGPPARATRPA1CTSSCTSK
SCHEMBL12241678 0.86 JAK3 (0.36) PPARGPPARAAAK1TRPA1PDE2A
SCHEMBL1595931 0.85 PPARG (0.47) PPARGPPARAAAK1AKR1C3AKR1C2
SCHEMBL5018934 0.85 AKR1C3 (0.39) AKR1C3AKR1C2MMP1MMP2MMP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2387570-A1 FLUOROISOQUINOLINE SUBSTITUTED THIAZOLE COMPOUNDS AND METHODS OF USE Amgen, Inc (US) 2011-11-23 EP disclosed
US-20110263647-A1 FLUOROISOQUINOLINE SUBSTITUTED THIAZOLE COMPOUNDS AND METHODS OF USE AMGEN INC. (US) 2011-10-27 US disclosed
WO-2010083246-A1 FLUOROISOQUINOLINE SUBSTITUTED THIAZOLE COMPOUNDS AND METHODS OF USE AMGEN INC. (US) 2010-07-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110263647-A1 FLUOROISOQUINOLINE SUBSTITUTED THIAZOLE COMPOUNDS AND METHODS OF USE TFEB, PCK2, JAK2 PPARG 232/4885PPARA 896/4885AAK1 588/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.